Independent fund research. Built on SEC filings.

How we research funds

ETF · Leveraged & Inverse · Direxion

CURE Performance & Returns History

Ticker CURE · · Holdings as of Jul 31, 2026

Expense ratio
0.94%$94/yr per $10k
5-yr return
+8.6%annualized
1-yr return
+22.9%as of Dec 2025
Net assets
$171.7Mall share classes
Holdings
67

Bottom line

How has CURE performed?

As of Dec 31, 2025, CURE returned +22.9% over the past year, +8.6% a year over five years, +13.6% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $35,700. Its five-year return beat 81% of leveraged & inverse funds we track. Its best quarter was +46.9% and its worst −45.8%.

Updated Dec 31, 2025

CURE annual returns by year

CURE calendar-year returns 2016: −17.4%; 2017: +69.3%; 2018: +2.9%; 2019: +55.9%; 2020: +5.1%; 2021: +87.4%; 2022: −20.4%; 2023: −9.8%; 2024: −8.5%; 2025: +22.9% −17% 2016 +69% 2017 +3% 2018 +56% 2019 +5% 2020 +87% 2021 −20% 2022 −10% 2023 −9% 2024 +23% 2025
Fund gain (+) Fund loss (−)
Year2025202420232022202120202019201820172016
CURE+22.9%−8.5%−9.8%−20.4%+87.4%+5.1%+55.9%+2.9%+69.3%−17.4%

Source: Fund prospectus bar chart (risk/return summary)

Growth of $10,000 in CURE

$10,000 invested at the start of 2016 would have been worth about $35,700 by the end of 2025, based on the fund's reported calendar-year returns.

YearReturnValue of $10,000
2025+22.9%$35,677
2024−8.5%$29,034
2023−9.8%$31,735
2022−20.4%$35,167
2021+87.4%$44,163
2020+5.1%$23,561
2019+55.9%$22,414
2018+2.9%$14,382
2017+69.3%$13,975
2016−17.4%$8,257

Trailing returns vs benchmark and category

1 yr5 yr10 yrSince inception
CURE+22.9%+8.6%+13.6%—
Leveraged & Inverse median−7.7%−11.8%−13.5%—

Source: Prospectus as of Dec 31, 2025; category medians computed by MutualFund.com

Recent monthly returns

For the three months ending Jul 31, 2026, CURE returned +6.29%, +18.95%, +5.39% (oldest to newest), per SEC Form N-PORT.

Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.